*COVID-19/epidemiology/prevention & control

Català, M. ., Mercadé-Besora, N. ., Kolde, R. ., Trinh, N. T. H., Roel, E. ., Burn, E. ., … Jödicke, A. M. (2024). The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia. Lancet Respir Med, 12, 225–236. http://doi.org/10.1016/s2213-2600(23)00414-9
Burn, E. ., Li, X. ., Delmestri, A. ., Jones, N. ., Duarte-Salles, T. ., Reyes, C. ., … Prieto-Alhambra, D. . (2022). Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in the United Kingdom. Nat Commun, 13, 7167. http://doi.org/10.1038/s41467-022-34668-w
Burn, E. ., Li, X. ., Kostka, K. ., Stewart, H. M., Reich, C. ., Seager, S. ., … Prieto-Alhambra, D. . (2022). Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries. Pharmacoepidemiol Drug Saf, 31, 495–510. http://doi.org/10.1002/pds.5419